A 58-year-old gentleman presented with history of fever and left loin pain for three months. On physical examination, he was found to have a renal mass. On laboratory evaluation he was found to be anaemic (PCV 23.8) with thrombocytosis (7,25,000/mm 3 ) and had an elevated ESR (77). His CT abdomen revealed an 11 x 13 cm heterogenously enhancing mass arising from the upper pole of left kidney [Table/ Fig-1 ]. There was no involvement of the contiguous structures but superiorly, it was adherent to the spleen.
Case RepoRt
A 58-year-old gentleman presented with history of fever and left loin pain for three months. On physical examination, he was found to have a renal mass. On laboratory evaluation he was found to be anaemic (PCV 23.8) with thrombocytosis (7, 25 ,000/mm 3 ) and had an elevated ESR (77). His CT abdomen revealed an 11 x 13 cm heterogenously enhancing mass arising from the upper pole of left kidney [Table/ Fig-1 ]. There was no involvement of the contiguous structures but superiorly, it was adherent to the spleen.
aBstRaCt
Malignant Fibrous Histiocytoma (MFH) usually arises from the extremities with the retroperitoneum being the second most common site. We present the case report of a 58-year-old man presenting with fever and was detected to have a renal mass on evaluation. He underwent a radical nephrectomy with a preoperative diagnosis of renal cell carcinoma. But the final histopathological report was MFH. Primary renal MFH is extremely rare and is usually diagnosed on histopathology with the aid of immunohistochemistry. 
DisCussion
MFH is a pleomorphic sarcoma arising from fibroblasts and histiocytes and was first described by O'brien and Stout in 1964 [1] . It is an extremely rare neoplasm and only 51 cases were reported till 2002 [2] . A few more cases have been reported since and have been highlighted [Table/ Fig-6 ]. 
HistopatHology
Gross: A well-circumscribed tumour was seen arising from the upper and interpole of the kidney. The cut surface was grayish white, homogenous with focal areas of yellowish and myxoid change. least common is the inflammatory subtype [13, 14] . The histology of this patient has been reported as inflammatory type of MFH.
It contains both fibrous and histiocytic elements. They stain positive for CD68 and anti α1 antichymotrysin but do not stain for cytokeratins [4] .
According the latest WHO update on renal sarcoma, MFH has been replaced with the term pleomorphic undifferentiated sarcoma after other forms of differentiation has been ruled out [15] . MFH is an aggressive tumour necessitating radical surgery with recurrence rates as high as 44%. It is associated metastases to lung (82%) and lymph nodes (32%) [13, 16] . The major predictors of outcome are size, depth of involvment and inflammatory component of tumour [13] . They also require adjuvant chemotherapy usually with Ifosfamide and doxorubicin owing to the high rates of local recurrence and metastasis. Anecdotal reports of response to adjuvant radiotherapy to the tumour bed are also reported in literature [17] . Despite aggressive treatment, local recurrence was seen in the first two years and mortality rate was 66% within the first year of radical nephrectomy [6] .
ConClusion
Malignant fibrous histiocytoma, now referred as undifferentiated pleomorphic sarcoma is a highly aggressive rare neoplasm with difficult preoperative diagnosis. Complete excision offers the only possible chance of cure with majority of patients succumbing to the illness in the first two years. Adjuvant therapy is of little or no benefit.
[table/ Fig-3 MFH presents in the 6-7 th decades of life usually, with nonspecific symptoms like fever, weight loss and non specific abdominal pain [2] . The most frequent site is the extremities (49%) followed by the retroperitoneum (16%) [2] . The male to female preponderance author year Pathology outcomes
Kitajima K et al., [3] 2003 MFH Post radical nephrectomy, no adjuvant therapy. Follow up till 30 months, patient asymptomatic.
Chen CH et al., [4] 2003 Giant cell subtype MFH Radical nephrectomy followed by 6 cycles of local irradiation and subsequent chemotherapy with doxorubicin and ifosfamide. Patient followed up for 12 months without evidence of tumour recurrence.
Erolu M et al., [5] 2005 MFH Radical nephrectomy with adjuvant RT with 6,600 rads. No recurrence at 15 months.
Singh SK et al., [6] 2006 MFH Patient died after 1 month of radical nephrectomy.
Ishibiki Y et al., [7] 2007 storiform-pleomorphic MFH arising from perirenal tissue
Refused adjuvant therapy after radical nephrectomy. Died due recurrence after 21 months.
Gupta R et al., [8] 2008 MFH Patient dies after 2 cylces of chemotherapy.
Ghosh A et al., [9] 2008 Inflammatory subtype of MFH No follow up.
Mellas S et al., [10] 2012 Pleomorphic undifferentiated sarcoma Post nephroureterectomy, refused adjuvant therapy. Died after 10 months.
Matsushita M et al [11] 2013 MFH arising from renal capsule Post radical nephrectomy, symptom free till 14 month post operatively.
[table/ Fig-6 ]: Case reports of MFH from [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] ratio is 2:1. The left kidney is more commonly affected [12] . MFH has been divided into five major classes by Enzinger: storiformpleomorphic, myxoid, giant cell, inflammatory and angiomatoid [13] . The most common is the storiform-pleomorphic while the 
